These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21129141)

  • 1. C-peptide and long-term complications of diabetes.
    Luppi P; Cifarelli V; Wahren J
    Pediatr Diabetes; 2011 May; 12(3 Pt 2):276-92. PubMed ID: 21129141
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proinsulin C-peptide -- the bioactive peptide with a huge promise].
    Walenciak Ł; Fendler W; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2007; 13(2):95-8. PubMed ID: 17880815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of C-peptide on microvascular blood flow and blood hemorheology.
    Forst T; Kunt T
    Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide.
    Joshua IG; Zhang Q; Falcone JC; Bratcher AP; Rodriguez WE; Tyagi SC
    J Cell Biochem; 2005 Dec; 96(6):1149-56. PubMed ID: 16187296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 diabetic neuropathy and C-peptide.
    Sima AA; Zhang W; Grunberger G
    Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.
    Johansson BL; Wahren J; Pernow J
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E864-70. PubMed ID: 12799312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
    Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
    Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiological effects of C-peptide].
    Tsimaratos M
    Nephrologie; 2004; 25(5):155-61. PubMed ID: 15455788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pleiotropic action of proinsulin C-peptide].
    Usarek M; Bryła J
    Postepy Hig Med Dosw (Online); 2012 Mar; 66():135-45. PubMed ID: 22470188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endothelial dysfunction in the development of vascular complications in diabetes mellitus].
    Dedov II; Shestakov MV; Kochemasova TV; Severina IS; Baryshnikov AIu
    Ross Fiziol Zh Im I M Sechenova; 2001 Aug; 87(8):1073-84. PubMed ID: 11601151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise and type I diabetes mellitus.
    Vitug A; Schneider SH; Ruderman NB
    Exerc Sport Sci Rev; 1988; 16():285-304. PubMed ID: 3292260
    [No Abstract]   [Full Text] [Related]  

  • 13. Complications of type 1 diabetes.
    Melendez-Ramirez LY; Richards RJ; Cefalu WT
    Endocrinol Metab Clin North Am; 2010 Sep; 39(3):625-40. PubMed ID: 20723824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is nitric oxide involved in the pathogenesis of the late complications of diabetes mellitus?].
    Amado JA; Berrazueta JR; Salas E
    Med Clin (Barc); 1995 Jul; 105(5):185-90. PubMed ID: 7630232
    [No Abstract]   [Full Text] [Related]  

  • 15. The influences of islet transplantation on metabolic abnormalities and diabetic complications.
    Hu YF; Cheng RL; Shao AH; Ye RS; Gu ZF; Zhang HD; Zhang ZG; Hen LR; Bi HF; Shi GF
    Horm Metab Res; 1989 Apr; 21(4):198-202. PubMed ID: 2502490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis and progression of neuropathies in diabetic patients with endothelial dysfunction].
    Naruse K; Nakamura J
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():516-20. PubMed ID: 15999762
    [No Abstract]   [Full Text] [Related]  

  • 17. Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?
    Luppi P; Kallas Å; Wahren J
    Diabetes Metab Res Rev; 2013 Jul; 29(5):357-62. PubMed ID: 23463541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.
    Sima AA
    J Neurol Sci; 2004 May; 220(1-2):133-6. PubMed ID: 15140622
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early detection of late complications of diabetes mellitus. Introduction].
    Igea García JM
    An Esp Pediatr; 1992; 37 Suppl 51():27-8. PubMed ID: 1492722
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of free radicals and reactive nitrogen species in the late complications of diabetes mellitus in rats].
    Stadler K; Jenei V; von Bölcsházy G; Somogyi A; Jakus J
    Orv Hetil; 2004 May; 145(21):1135-40. PubMed ID: 15206194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.